Market News & Trends
Cyclacel Announces Phase II Trial of Sapacitabine
Cyclacel Pharmaceuticals, Inc. recently announced that the first patient has been dosed in an investigator-initiated, translational, Phase II clinical study at The University of Texas…
Jennerex's Virus-Based Drug Targets & Infects Tumors
Jennerex, Inc. recently announced the publication of clinical data on its lead product JX-594. For the first time in humans, an oncolytic virus was shown…
Marina Biotech Granted US Patent Related to Nucleic Acid-Peptide Drug Delivery Platform
Marina Biotech, Inc. recently announced the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application US 11/955,207 with claims…
MonoSol Rx Announces Second PharmFilm Product
MonoSol Rx, LLC recently announced it plans to develop a second oral film product for the treatment of attention-deficit hyperactivity disorder (ADHD) with its partner…
Oxford BioTherapeutics Licenses Lonza's GS Gene Expression System
Oxford BioTherapeutics Ltd and Lonza recently announced a non-exclusive license agreement providing OBT with access to Lonza's GS Gene Expression System. The agreement covers the…
Unilife Develops Proprietary Range of Auto-Injectors
Unilife Corporation recently announced the development of a unique proprietary range of auto-injectors for the self-administration of injectable drugs by patients outside of healthcare facilities.…
9/6/2011
Jennerex's Virus-Based Drug Targets & Infects Tumors Jennerex, Inc. recently announced the publication of clinical data on its lead product JX-594. For the first time…
8/30/2011
Avantor Performance Materials Expands Portfolio Avantor Performance Materials recently announced it has expanded its portfolio by offering cGMP-manufactured Methylene Chloride and Acetone produced at its…
apceth Starts First Phase I/II Clinical Study on Somatic Cell Therapy for pAOD
The Munich biotech company apceth recently announced it started its first Phase I/II clinical study on somatic cell therapy for advanced peripheral arterial occlusive disease…
Avantor Performance Materials Expands Portfolio
Avantor Performance Materials recently announced it has expanded its portfolio by offering cGMP-manufactured Methylene Chloride and Acetone produced at its manufacturing facility in Phillipsburg, NJ.…
Bend Research & Xcelience Form Partnership to Speed Drug Product Intermediates to Early Phase Clinical Trials
Bend Research Inc. and Xcelience LLC recently announced they have formed a collaboration to provide oral solid-solubilization formulation solutions and expedited clinical supply manufacture in…
Rexam Healthcare Receives 510(k) FDA Approval
Rexam Healthcare recently announced it has received 510(k) approval from the Food and Drug Administration (FDA) for Safe'n'Sound, its passive safety device for staked prefilled…
Tekmira Acquires Worldwide Exclusive License to Novel RNAi Platform
Tekmira Pharmaceuticals Corporation recently announced it has obtained an exclusive, worldwide license to a novel and proprietary RNAi technology called MV-RNA (multivalent RNA) from Halo-Bio…
Unilife Develops Multiple-Chamber Prefilled Syringes
Unilife Corporation recently announced the development and patenting of the Unifill EZMix multiple-chamber ready-to-fill (prefilled) syringes. Unifill EZMix syringes have been developed in direct response…
Encap Drug Delivery Introduces Colon-Screen
Encap Drug Delivery recently announced it is now offering a feasibility package that will evaluate the potential to use candidate compounds in formulations suitable for…
Evonik Establishes New Health Care Business Line
Evonik Industries AG recently announced it will combine its business in custom manufacturing of APIs (exclusive synthesis), pharmaceutical amino acids (Rexim) and pharmaceutical polymers in…
Intellipharmaceutics & Par Pharmaceutical Expand Development & Commercialization Agreement
Intellipharmaceutics International Inc. recently announced that they have added the development and commercialization of additional strengths of generic Focalin XR (dexmethylphenidate hydrochloride) for the US…
Xcelience to Expand, Plans to Hire 45 Employees
Xcelience, a Tampa, FL-based contract research organization, recently announced it is expanding its footprint and more than doubling its employment over the next 3 years.…
8/23/2011
Intellipharmaceutics & Par Pharmaceutical Expand Development & Commercialization Agreement Intellipharmaceutics International Inc. recently announced that they have added the development and commercialization of additional strengths…
Alexza Pharmaceuticals Announces PDUFA Goal Date
Alexza Pharmaceuticals, Inc. recently announced the US FDA has accepted the ADASUVE NDA as a complete, class 2 response to the FDA's action letter, with…
